Aman M. G. et al. (2005)
Acute and long-term safety and tolerability of risperidone in children with autism.
Journal of Child and Adolescent Psychopharmacology
15(6), pp. 869-884
Aman M. G. et al. (2008)
Cognitive effects of risperidone in children with autism and irritable behavior.
Journal of Child and Adolescent Psychopharmacology
18(3), pp. 227-236
Aman M. G. et al. (2009)
Journal of the American Academy of Child and Adolescent Psychiatry
48(12), pp. 1143-1154
Aman M. G. et al. (2015)
Journal of Child and Adolescent Psychopharmacology
August, 25(6), pp. 482-493.
Anderson G. M. et al. (2007)
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.
February, 61(4), pp. 545-550.
Arnold L. E. et al. (2003)
Journal of the American Academy of Child and Adolescent Psychiatry
42(12), pp. 1443-1450
Arnold L. E. et al. (2012)
Journal of the American Academy of Child and Adolescent Psychiatry
51(11), pp. 1173-1184.
Bearss K. E. et al. (2015)
Parent training in autism spectrum disorder: What's in a name?
Clinical Child and Family Psychology Review
June, 18(2), pp.170-182.
Carroll D. et al. (2014)
Child and Adolescent Psychiatric Clinics of North America
January, 23(1), pp. 57-72.
Erickson C. A. et al. (2014)
STX209 (Arbaclofen) for autism spectrum disorders: An 8-week open-label study.
Journal of Autism and Developmental Disorders
44(4), pp. 958-964.
Yale Journal of Biology and Medicine
Journal of Autism and Developmental Disorders
39(8), pp. 1163-1172